HEADER HYDROLASE/HYDROLASE INHIBITOR 20-MAY-09 3HIO
TITLE CRYSTAL STRUCTURE OF RICIN A-CHAIN IN COMPLEX WITH THE CYCLIC
TITLE 2 TETRANUCLEOTIDE INHIBITOR, A TRANSITION STATE ANALOGUE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RICIN;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: RICIN A CHAIN, RRNA N-GLYCOSIDASE;
COMPND 5 EC: 3.2.2.22;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: RICINUS COMMUNIS;
SOURCE 3 ORGANISM_COMMON: CASTOR BEAN;
SOURCE 4 ORGANISM_TAXID: 3988;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: C43;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET23A
KEYWDS RTA, TRANSITION STATE, RIBOSOME INACTIVATING PROTEINS, RIPS,
KEYWDS 2 DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, LECTIN, NUCLEOTIDE-BINDING,
KEYWDS 3 PLANT DEFENSE, PROTEIN SYNTHESIS INHIBITOR, TOXIN, HYDROLASE-
KEYWDS 4 HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR M.HO,M.B.STURM,J.D.GOLDMAN,S.C.ALMO,V.L.SCHRAMM
REVDAT 5 21-FEB-24 3HIO 1 REMARK SEQADV
REVDAT 4 01-NOV-17 3HIO 1 REMARK
REVDAT 3 13-JUL-11 3HIO 1 VERSN
REVDAT 2 15-DEC-09 3HIO 1 JRNL
REVDAT 1 08-DEC-09 3HIO 0
JRNL AUTH M.C.HO,M.B.STURM,S.C.ALMO,V.L.SCHRAMM
JRNL TITL TRANSITION STATE ANALOGUES IN STRUCTURES OF RICIN AND
JRNL TITL 2 SAPORIN RIBOSOME-INACTIVATING PROTEINS.
JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 20276 2009
JRNL REFN ISSN 0027-8424
JRNL PMID 19920175
JRNL DOI 10.1073/PNAS.0911606106
REMARK 2
REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.5.0066
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7
REMARK 3 NUMBER OF REFLECTIONS : 22185
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.221
REMARK 3 R VALUE (WORKING SET) : 0.219
REMARK 3 FREE R VALUE : 0.254
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1139
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1487
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.61
REMARK 3 BIN R VALUE (WORKING SET) : 0.2410
REMARK 3 BIN FREE R VALUE SET COUNT : 81
REMARK 3 BIN FREE R VALUE : 0.2590
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2042
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 111
REMARK 3 SOLVENT ATOMS : 63
REMARK 3
REMARK 3 B VALUES.
REMARK 3 B VALUE TYPE : LIKELY RESIDUAL
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.98
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.62000
REMARK 3 B22 (A**2) : 0.62000
REMARK 3 B33 (A**2) : -1.23000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.193
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.169
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.102
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.871
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2230 ; 0.014 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3062 ; 1.557 ; 2.014
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 266 ; 5.053 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 104 ;34.076 ;22.981
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 329 ;14.328 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;18.310 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 337 ; 0.097 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1701 ; 0.008 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1306 ; 0.778 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2120 ; 1.455 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 924 ; 2.538 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 939 ; 4.221 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 5 A 263
REMARK 3 ORIGIN FOR THE GROUP (A): -26.6670 14.9350 9.0800
REMARK 3 T TENSOR
REMARK 3 T11: 0.2015 T22: 0.1611
REMARK 3 T33: 0.1809 T12: 0.0252
REMARK 3 T13: -0.0328 T23: 0.0111
REMARK 3 L TENSOR
REMARK 3 L11: 0.8906 L22: 1.2484
REMARK 3 L33: 2.6129 L12: -0.6686
REMARK 3 L13: 1.2494 L23: -0.9100
REMARK 3 S TENSOR
REMARK 3 S11: 0.2109 S12: 0.0029 S13: -0.1415
REMARK 3 S21: -0.2133 S22: -0.0203 S23: 0.1324
REMARK 3 S31: 0.3096 S32: 0.0126 S33: -0.1906
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3HIO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-09.
REMARK 100 THE DEPOSITION ID IS D_1000053181.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 04-DEC-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 4.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : NSLS
REMARK 200 BEAMLINE : X29A
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.081
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22257
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000
REMARK 200 RESOLUTION RANGE LOW (A) : 61.200
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9
REMARK 200 DATA REDUNDANCY : 8.200
REMARK 200 R MERGE (I) : 0.05900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 30.0770
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6
REMARK 200 DATA REDUNDANCY IN SHELL : 7.80
REMARK 200 R MERGE FOR SHELL (I) : 0.52300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 55.11
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG2000, 0.2M LITHIUM SULFATE,
REMARK 280 0.1M SODIUM ACETATE, PH 4.5, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.34050
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 34.31600
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 34.31600
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.67025
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 34.31600
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 34.31600
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 101.01075
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 34.31600
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 34.31600
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 33.67025
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 34.31600
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 34.31600
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 101.01075
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 67.34050
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 0
REMARK 465 ILE A 1
REMARK 465 PHE A 2
REMARK 465 PRO A 3
REMARK 465 LYS A 4
REMARK 465 SER A 264
REMARK 465 SER A 265
REMARK 465 GLN A 266
REMARK 465 PHE A 267
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLN A 5 CG CD OE1 NE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE2 GLU A 220 SG CYS A 259 2.15
REMARK 500 ND1 HIS A 40 O HOH A 282 2.15
REMARK 500 OG1 THR A 206 O HOH A 284 2.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 OD1 ASP A 244 OD1 ASP A 244 8555 2.13
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 78 14.28 -145.25
REMARK 500 ILE A 175 -71.49 -109.95
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C2X A 268
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 269
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3HIQ RELATED DB: PDB
REMARK 900 RELATED ID: 3HIS RELATED DB: PDB
REMARK 900 RELATED ID: 3HIT RELATED DB: PDB
REMARK 900 RELATED ID: 3HIV RELATED DB: PDB
REMARK 900 RELATED ID: 3HIW RELATED DB: PDB
DBREF 3HIO A 1 267 UNP P02879 RICI_RICCO 36 302
SEQADV 3HIO MET A 0 UNP P02879 EXPRESSION TAG
SEQRES 1 A 268 MET ILE PHE PRO LYS GLN TYR PRO ILE ILE ASN PHE THR
SEQRES 2 A 268 THR ALA GLY ALA THR VAL GLN SER TYR THR ASN PHE ILE
SEQRES 3 A 268 ARG ALA VAL ARG GLY ARG LEU THR THR GLY ALA ASP VAL
SEQRES 4 A 268 ARG HIS GLU ILE PRO VAL LEU PRO ASN ARG VAL GLY LEU
SEQRES 5 A 268 PRO ILE ASN GLN ARG PHE ILE LEU VAL GLU LEU SER ASN
SEQRES 6 A 268 HIS ALA GLU LEU SER VAL THR LEU ALA LEU ASP VAL THR
SEQRES 7 A 268 ASN ALA TYR VAL VAL GLY TYR ARG ALA GLY ASN SER ALA
SEQRES 8 A 268 TYR PHE PHE HIS PRO ASP ASN GLN GLU ASP ALA GLU ALA
SEQRES 9 A 268 ILE THR HIS LEU PHE THR ASP VAL GLN ASN ARG TYR THR
SEQRES 10 A 268 PHE ALA PHE GLY GLY ASN TYR ASP ARG LEU GLU GLN LEU
SEQRES 11 A 268 ALA GLY ASN LEU ARG GLU ASN ILE GLU LEU GLY ASN GLY
SEQRES 12 A 268 PRO LEU GLU GLU ALA ILE SER ALA LEU TYR TYR TYR SER
SEQRES 13 A 268 THR GLY GLY THR GLN LEU PRO THR LEU ALA ARG SER PHE
SEQRES 14 A 268 ILE ILE CYS ILE GLN MET ILE SER GLU ALA ALA ARG PHE
SEQRES 15 A 268 GLN TYR ILE GLU GLY GLU MET ARG THR ARG ILE ARG TYR
SEQRES 16 A 268 ASN ARG ARG SER ALA PRO ASP PRO SER VAL ILE THR LEU
SEQRES 17 A 268 GLU ASN SER TRP GLY ARG LEU SER THR ALA ILE GLN GLU
SEQRES 18 A 268 SER ASN GLN GLY ALA PHE ALA SER PRO ILE GLN LEU GLN
SEQRES 19 A 268 ARG ARG ASN GLY SER LYS PHE SER VAL TYR ASP VAL SER
SEQRES 20 A 268 ILE LEU ILE PRO ILE ILE ALA LEU MET VAL TYR ARG CYS
SEQRES 21 A 268 ALA PRO PRO PRO SER SER GLN PHE
HET C2X A 268 106
HET SO4 A 269 5
HETNAM C2X 9,9'-{(2R,3R,3AR,5S,7AR,9R,10R,10AR,12S,23R,25AR,27R,
HETNAM 2 C2X 28R,28AR,30S,32AR,35AR,37S,39AR)-9-(6-AMINO-9H-PURIN-
HETNAM 3 C2X 9-YL)-34-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)
HETNAM 4 C2X METHYL]-5,12,23,30,37-PENTAHYDROXY-3,10,28-TRIMETHOXY-
HETNAM 5 C2X 5,12,23,30,37-PENTAOXIDOTETRACOSAHYDRO-2H,7H,25H-
HETNAM 6 C2X TRIFURO[3,2-F:3',2'-L:3'',2''-X]PYRROLO[3,4-R][1,3,5,
HETNAM 7 C2X 9,11,15,17,21,23,27,29,2,4,10,16,22,
HETNAM 8 C2X 28]UNDECAOXAZAPENTAPHOSPHACYCLOPENTATRIACONTINE-2,27-
HETNAM 9 C2X DIYL}BIS(2-AMINO-3,9-DIHYDRO-6H-PURIN-6-ONE)
HETNAM SO4 SULFATE ION
FORMUL 2 C2X C51 H72 N21 O29 P5
FORMUL 3 SO4 O4 S 2-
FORMUL 4 HOH *63(H2 O)
HELIX 1 1 THR A 17 THR A 33 1 17
HELIX 2 2 PRO A 52 GLN A 55 5 4
HELIX 3 3 ASN A 97 THR A 105 1 9
HELIX 4 4 ASN A 122 GLY A 131 1 10
HELIX 5 5 LEU A 133 ILE A 137 5 5
HELIX 6 6 GLY A 140 SER A 155 1 16
HELIX 7 7 GLN A 160 ILE A 175 1 16
HELIX 8 8 ILE A 175 PHE A 181 1 7
HELIX 9 9 PHE A 181 TYR A 194 1 14
HELIX 10 10 ASP A 201 GLU A 220 1 20
HELIX 11 11 SER A 246 ILE A 249 5 4
SHEET 1 A 6 ILE A 8 THR A 12 0
SHEET 2 A 6 PHE A 57 SER A 63 1 O LEU A 59 N ILE A 9
SHEET 3 A 6 SER A 69 ASP A 75 -1 O VAL A 70 N LEU A 62
SHEET 4 A 6 VAL A 81 ALA A 86 -1 O GLY A 83 N ALA A 73
SHEET 5 A 6 SER A 89 PHE A 92 -1 O TYR A 91 N TYR A 84
SHEET 6 A 6 ASN A 113 THR A 116 1 O ASN A 113 N ALA A 90
SHEET 1 B 2 ASP A 37 ARG A 39 0
SHEET 2 B 2 ILE A 42 VAL A 44 -1 O VAL A 44 N ASP A 37
SHEET 1 C 2 ALA A 225 GLN A 233 0
SHEET 2 C 2 LYS A 239 ASP A 244 -1 O PHE A 240 N LEU A 232
SITE 1 AC1 24 ASP A 75 ASN A 78 ALA A 79 TYR A 80
SITE 2 AC1 24 VAL A 81 PRO A 95 ASP A 96 ASP A 100
SITE 3 AC1 24 GLY A 121 TYR A 123 ASP A 124 ILE A 172
SITE 4 AC1 24 GLU A 177 ARG A 180 ARG A 189 THR A 190
SITE 5 AC1 24 ARG A 193 TYR A 194 ASN A 209 TRP A 211
SITE 6 AC1 24 GLY A 212 ARG A 213 ARG A 258 HOH A 321
SITE 1 AC2 3 THR A 17 HIS A 65 HOH A 271
CRYST1 68.632 68.632 134.681 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014570 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014570 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007425 0.00000